Translational control in T lymphocytes

International Reviews of Immunology

Volumn 23, Issue 3-4, 2004, Pages 347-363

  Beretta, Laura ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Initiation factors; MRNA; PKR; SLE; T cells; Translation

Indexed keywords

CYTOKINE; GENE PRODUCT; GROWTH FACTOR; PROTEIN;

APOPTOSIS; CYTOKINE PRODUCTION; GENE EXPRESSION; GENOMICS; GROWTH REGULATION; HUMAN; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TRANSLATION REGULATION;

EUKARYOTIC INITIATION FACTOR-4E; GENE EXPRESSION REGULATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; RNA, TRANSFER; T-LYMPHOCYTES;

EID: 3042571215     PISSN: 08830185     EISSN: None     Source Type: Journal    
DOI: 10.1080/08830180490452549     Document Type: Review

References (103)

1. V.M. Pain, Initiation of protein synthesis in eukaryotic cells, Eur. J. Biochem., 236: 747-771, 1996.
2. N. Sonenberg, RNA 5′-cap-binding protein elF4E and control of cell growth. Translational Control, (N. Sonenberg, J.W.B. Hershey, M.B. Mathews eds.) Cold Spring Harbor Laboratory Press, pp. 245-269, 1996.
3. D.R. Morris, Growth control of translation in mammalian cells, Prog. Nucleic Acids Res. Mol. Biol., 51: 339-363, 1995.
4. V.A. Polunovsky, I.B. Rosenwald, A.T. Tan, J. White, L. Chiang, N. Sonenberg, and P.B. Bitterman, Translational control of programmed cell death: Eukaryotic translation initiation factor 4E blocks apoptosis in growth-factor-restricted fibroblasts with physiologically expressed or deregulated Myc, Mol. Cell. Biol., 16: 6573-6581, 1996.
5. W.E. Marissen and R.E. Lloyd, Eukaryotic translation initiation factor 4G is targeted for proteolytic cleavage by caspase 3 during inhibition of translation in apoptotic cells, Mol. Cell. Biol., 18: 7565-7574, 1998.
6. M.E. Tome, S.M. Fiser, C.M Payne, and E.W. Gerner, Excess putrescine accumulation inhibits the formation of modified eukaryotic initiation factor 5A (elF-5A) and induces apoptosis, Biochem. J., 328: 847-854, 1997.
7. J. Gil, J. Alcami, and M. Esteban, Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the alpha subunit of eukaryotic translation initiation factor 2 and NF-kappaB, Mol. Cell. Biol., 19: 4653-4663, 1999.
8. N. Sonenberg, Translation factors as effectors of cell growth and tumorigenesis, Curr. Opin. Cell Biol., 5: 955-960, 1993.
9. A. Flynn, and C.G. Proud, The role of elF4 in cell proliferation, Cancer Surv., 27: 293-310, 1996.
10. M. Kozak, An analysis of vertebrate mRNA sequences: Intimations of translational control, J. Cell. Biol., 115: 887-903, 1991.
11. M. Kozak, An analysis of 5′-noncoding sequences from 699 vertebrate meesenger RNAs, Nucleic Acid. Res., 15: 8125-8148, 1987.
12. A.E. Willis, Translational control of growth factor and proto-oncogene expression, Int. J. Biochem. Cell. Biol., 31: 73-86, 1999.
13. R.C. Muise-Helmericks, H.L. Grimes, A. Bellacosa, S.E. Malstrom, P.N. Tsichlis, and N. Rosen, Cyclin D expression is controlled post-transcriptionally via a phosphatidy linositol 3-kinase/Akt-dependent pathway, J. Biol. Chem., 273: 29864-29872, 1998.
14. R.S. Allison, M.L. Mumy, and L.M. Wakefield, Translational control elements in the major human transforming growth factor-beta 1 mRNA, Growth Factors, 16: 89-100, 1998.
15. V. Kruys, O. Marinx, G. Shaw, J. Deschamps, and G. Huez, Translational blockade imposed by cytokine-derived UA-rich sequences, Science, 245: 852-855, 1989.
16. J.A. Garcia-Sanz and D. Lenig, Translational control of interleukin-2 messenger RNA as a molecular mechanism of T cell energy, J. Exp. Med., 184: 159-164, 1996.
17. E. Espel, J.A. Garcia-Sanz, V. Aubert, V. Menoud, P. Sperisen, N. Fernandez, and F. Spertini, Transcriptional and translational control of TNF-alpha gene expression in human monocytes by major histocompatibility complex class II ligands, Eur. J. Immunol., 26: 2417-2424, 1996.
18. T. Raabe, M. Bukrinsky, and R.A. Currie, Relative contibution of transcription and translation to the induction of tumor necrosis factor-alpha by lipopolyscharide, J. Biol. Chem., 273: 974-980, 1998.
19. C. Gueydan, L. Droogmams, P. Chalon, G. Huez, D. Caput, and V. Kruys, Identification of TIAR as a protein binding to the translational regulatory AU-rich element of tumor necrosis factor alpha mRNA, J. Biol. Chem., 274: 2322-2326, 1999.
20. E. Gonalons, M. Barrachina, J.A. Garcia-Sanz, and A. Celada, Translational contol of MHC class II I-A molecules by IFN-gamma, J. Immunol., 161: 1837-1843, 1998.
21. W.C. Merrick and J.W.B Hershey, The pathway and mechanism of eukaryotic protein synthesis, In J.W.B. Hershey, M.B. Mathews, and N. Sonenberg (Eds.), Translational Control, Cold Spring Harbor: CSHL Press, pp. 31-69, 1996.
22. A.J. Shatkin, mRNA cap binding proteins: Essential factors for initiation translation, Cell, 40: 223-224, 1985.
23. N. Sonenberg, M.A. Morgan, W.C. Merrick, and A.J. Shatkin, A polypeptide in eukaryotic initiation factors that crosslinks specifically to the 5′-terminal cap in mRNA, Proc. Natl. Acad. Sci., 75: 4843-4847, 1978.
24. A. Lazaris-Karatzas, K.S. Montine, and N. Sonenberg, Malignant transformation by a eukarotic initiation factor subunits that binds to mRNA 5′ cap, Nature, 345: 44-547, 1990.
25. V.A. Polunovsky, I.B. Rosenwald, A.T. Tan, J. White, L. Chiang, N. Sonenberg, and P.B. Bitterman, Translational control of programmed cell death: Eukaryotic translation initiation factor 4E blocks apoptosis in growth-factor-restricted fibroblasts with physiologically expressed or deregulated, Myc, Mol. Cell. Biol., 16: 6573-6581, 1996.
26. A. Tan, P. Bitterman, N. Sonenberg, M. Peterson, and V. Polunovsky, Inhibition of Myc-dependent apoptosis by eukaryotic translation initiation factor 4E requires cyclin D1, Oncogene, 19: 1437-1447, 2000.
27. R.M. Jones, J. Branda, K.A. Johnston, M. Polymenis, M. Gadd, A. Rustgi, L. Callanan, and E.V. Schmidt, An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc, Mol. Cell. Biol., 16: 4754-4764, 1996.
28. S. Joshi-Barve, W. Rychlik, and R.E. Rhoads, Alteration of the major phosphorylation site of eukaryotic protein synthesis initiation factor 4E prevents its association with the 48 S initiation complex, J. Biol. Chem., 265: 2979-2983, 1990.
29. S.J. Morley, T.E. Dever, D. Etchison, and J.A. Traugh, Phosphorylation of elF4F by protein kinase C or multipotential S6 kinase stimulates protein synthesis at initiation, J. Biol. Chem., 266: 4669-4672, 1991.
30. A.J. Waskiewicz, A. Flynn, C.G. Proud, J.A. Proud, and J.A. Cooper, Mitogen-activated protein kinases activate the serine/threonine kinases Mnkl and Mnk2, EMBO J., 16: 1909-1920, 1997.
31. R. Fukunaga and T. Hunter, MNK1, a new MAP-kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrate, EMBO J., 16: 1921-1933, 1997.
32. T.-A. Lin, X. Kong, T.A.J. Haystead, A. Pause, G. Belsham, N. Sonenberg, and J.C. Lawrence Jr., PHAS-I as a link between mitogen-activated protein kinase and translation initiation, Science, 266: 653-656, 1994.
33. A. Pause, G.J. Belsham, A.C. Gingras, O. Donze, T.A. Lin, J.C. Lawrence Jr., and N. Sonenberg, Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function, Nature, 371: 762-767, 1994.
34. A. Haghighat, S. Mader, A. Pause, and N. Sonenberg, Represson of cap-dependent translation by 4E-binding protein 1: Competition with p220 for binding to eukaryotic initiation factor-4E, EMBO J., 14: 5701-5709, 1995.
35. A. De Benedetti, S. Joshi-Barve, C. Rinker-Schaeffer, and R. E. Rhoads, Mol. Cell. Biol., 11: 5435-5445, 1991.
36. D. Rousseau, A. C. Gingras, A. Pause, and N. Sonenberg, The elF4E-binding proteins 1 and 2 are negative regulators of cell growth, Oncogene, 13: 2415-2420, 1996.
37. V.A. Polunovsky, A.C. Gingras, N. Sonenberg, M. Peterson, A. Tan, J.B. Rubins, J.C. Manivel, and P.B. Bitterman, Translational control of the antiapoptotic function of Ras, J. Biol. Chem., 275: 24776-24780, 2000.
38. A.E. Koromilas, A. Lazaris-Karatzas, and N. Sonenberg, mRNAs containing extensive secondary structure in their 5′ non-coding region translate efficiently in cells overexpressing initiation factor elF-4E, EMBO J., 11: 4153-4158, 1992.
39. I.B. Rosenwald, A. Lazaris-Karatzas, N. Sonenberg, and E.V. Schmidt, Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E, Mol. Cell. Biol., 13: 7358-7363, 1993.
40. I.B. Rosenwald, R. Kaspar, D. Rousseau, L. Gehrke, P. Leboulch, J.J. Chen, E.V. Schmidt, N. Sonenberg, and I.M. London, Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and post-transcriptional levels, J. Biol. Chem., 270: 21176-21180, 1995.
41. D. Rousseau, R. Kaspar, I. Rosenwald, L. Gehrke, and N. Sonenberg, Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E, Proc. Natl. Acad. Sci. USA, 93: 1065-1070, 1996.
42. L.M. Shantz, R.H. Hu, and A.E. Pegg, Regulation of ornithine decarboxylase in a transformed cell line that overexpresses translation initiation factor elF-4E, Cancer Res., 56: 3265-3269, 1996.
43. J.R. Graff, A. De Benedetti, J.W. Olson, P. Tamez, R.A. Casero Jr., and S.G. Zimmer, Translation of ODC mRNA and polyamine transport are suppressed in ras-transformed CREF cells by depleting translation initiation factor 4E, Biochem. Biophys. Res. Commun., 240: 15-20, 1997.
44. S.R. Kimball, Eukaryotic initiation factor elF2, Int. J. Biochem. Cell Biol., 31: 25-29, 1999.
45. C. De Haro, R. Mendez, and J. Santoyo, The elF-2alpha kinases and the control of protein synthesis, FASEB J., 10: 1378-1387, 1996.
46. A.G. Hovanessian, dsRNA-activated protein kinase (PKR): Antiproliferative antiviral and antitumoral functions, Semin. Virol., 4: 237-245, 1993.
47. M.J. Clemens and A. Elia, The double stranded RNA-dependent protein kinase PKR: Structure and function, J. Interferon Cytokine Res., 17: 503-524, 1997.
48. R. Jagus, B. Joshi, and G. N. Barber, PKR apoptosis and cancer, Int. J. Biochem. Cell Biol., 31: 123-138, 1999.
49. R. Kaufman and S.P. Srivasyava, PKR: A general transducer of the cellular stress response leading to apoptosis, in Translational Control, Sonenberg, N., Hershey, J.W.B., Mathews, M.B., eds. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1996.
50. A.E. Koromilas, S. Roy, G.N. Barber, M. Katze, and N. Sonenberg, Malignant transormation by a mutant of the IFN-inducible dsRNA-dependent protein kinase, Science, 257: 5041-5044, 1992.
51. K.L. Chong, L. Feng, K. Schappert, E. Meurs, T.F. Donohue, J.D. Friesen, A.G. Hovanessian, and B.R.G. Williams, Human p68 kinase (PKR) exhibits growth suppression in yeast and homology to the translational regulator GCN2, EMBO J., 11: 1553-1562, 1992.
52. S.B. Lee and M. Esteban, The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis, Virology, 199: 491-496, 1994.
53. M.C. Yeung, J. Liu, and A.S. Lau, An essential role for the interferon-inducible, dsRNA-activated protein kinase, PKR, in the tumor necrosis factor-induced apoptosis in U937 cells, Proc. Natl. Acad. Sci., 93: 12451-12455, 1996.
54. S.D. Der, Y.L. Yang, C. Weissman, and B.R. Williams, A dsRNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis, Proc. Natl. Acad. Sci., 94: 3279-3283, 1997.
55. S.B. Lee, D. Rodriguez, J.R. Rodriguez, and M. Esteban, The apoptosis pathway triggered by the interferon-induced protein kinase, PKR requires the third basic domain, initiates upstream of Bcl-2, and involves ICE-like proteases, Virology, 231: 81-88, 1997.
56. S.P. Srivastava, K.U. Kumar, and R.J. Kaufman, Phosphorylation of elF2 mediates apoptosis in response to activation of PKR, J. Biol. Chem., 273: 2416-2423, 1998.
57. O. Donze, J. Dostie, and N. Sonenberg, Regulatable expression of the interferon-induced double-stranded RNA dependent protein kinase PKR induces apoptosis and Fas receptor expression, Virology, 256: 322-329, 1999.
58. S. Balachandran, N. Kim, W.-C. Yeh, T.W. Mak, K. Bhalla, and G.N. Barber, Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling, EMBO J., 17: 6888-6902, 1998.
59. P. Jedlicka and R. Panniers, Mechanism of activation of protein synthesis initiation in mitogen-stimulated T lymphocytes, J. Biol. Chem., 266: 15663-15669, 1991.
60. R.B. Cohen, T.R. Boal, and B. Safer, Increased elF-2 alpha expression in mitogen-activated primary T lymphocytes, EMBO J., 9: 3831-3837, 1990.
61. X. Mao, J.M. Green, B. Safer, T. Lindsten, R.M. Frederickson, S. Miyamoto, N. Sonqnberg, and C.B. Thompson, Regulation of translation initiation factor gene expression during human T cell activation, J. Biol. Chem., 267: 20444-20450, 1992.
62. T.R. Boal, J.A. Chiorini, R.B. Cohen, S. Miyamoto, R.M. Frederickson, N. Sonenberg, and B. Safer, Regulation of eukaryotic translation initiation factor expression during T-cell activation, Biochim. Biophys. Acta., 1176: 257-264, 1993.
63. J.A. Garcia-Sanz, W. Mikulits, A. Livingstone, I. Lefkovits, and E.W. Mullner, Translational control: A general mechanism for gene regulation during T cell activation, FASEB J., 12: 299-306, 1998.
64. S.J. Morley, Signalling through either the p38 or ERK mitogen-activated protein (MAP) kinase pathway is obligatory for phorbol ester and T cell receptor complex (TCR-CD3)-stimulated phosphorylation of initiation factor (elF) 4E in jurkat T cells, FEBS Lett., 418: 327-332, 1997.
65. M.J. Clemens, M. Bushell, and S.J. Morley, Degradation of eukaryotic polypeptide chain initiation factor (elF) 4G in response to induction of apoptosis in human lymphoma cell lines, Oncogene, 17: 2921-2931, 1998.
66. S.J. Morley, L. McKendrick, and M. Bushell, Cleavage of translation initiation factor 4G (elF4G) during anti-Fas IgM-induced apoptosis does not require signalling through the p38 mitogen-activated protein (MAP) kinase, FEBS Lett., 438: 41-48, 1998.
67. E.J. Brown, M.W. Albers, T.B. Shin, K. Ichikawa, C.T. Keith, W.S. Lane, and S.L. Schreiber, A mammalian protein targeted by G1-arresting rapamycin-receptor complex, Nature, 369: 756-758, 1994.
68. D.M. Sabatini, H. Erdjument-Bromage, M. Lui, P. Tempst, and S.H. Snyder, RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs, Cell, 78: 35-43, 1994.
69. R. Stan, M.M. McLaughlin, R. Cafferkey, R.K. Johnson, M. Rosenberg, and G.P. Livi, Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue, J. Biol. Chem., 269: 32027-32030, 1994.
70. C.J. Sabers, M.M. Martin, G.J. Brunn, J.M. Williams, F.J. Dumont, G. Wiederrecht, and R.T. Abraham, Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells, J. Biol. Chem., 270: 815-822, 1995.
71. L. Beretta, A.C. Gingras, Y. Svitkin, M.N. Hall, and N. Sonenberg, Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation EMBO J., 15: 658-664, 1996.
72. L. Beretta and A. Grolleau, Rapamycin selectively inhibits a growth-dependent activation of the initiation step of translation, Med. Sci., 5: 600-602, 1998.
73. E.J. Brown and S.L. Schreiber, A signaling pathway to translational control, Cell, 86: 517-520, 1996.
74. T.F. Franke, D.R. Kaplan, and L.C. Cantley, PI3K: Downstream AKTion blocks apoptosis, Cell, 88: 435-437, 1997.
75. J. Downward, Mechanisms and consequences of activation of protein kinase B/Akt, Curr. Opin. Cell. Biol., 10: 262-267, 1998.
76. L. Beretta, N.G. Singer, R. Hinderer, A.C. Gingras, B. Richardson, S.M. Hanash, and N. Sonenberg, Differential regulation of translation and elF4E phosphorylation during human thymocyte maturation, J. Immunol., 160: 3269-3273, 1998.
77. B.J. Fowlkes and D.M. Pardoll, Molecular and cellular events of T cell development, Adv. Immunol., 44: 207-264, 1989.
78. L.A. Husman, R.P. Shimonkevitz, I.N. Crispe, and M.J. Bevan, Thymocyte subpopulations during early fetal development in the BALB/c mouse, J. Immunol., 141: 736-740, 1988.
79. E.L. Reinherz, P.C. Kung, G. Goldstein, R.H. Levey, and S.F. Schlossman, Discrete stages of human intrathymic differentiation: Analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage, Proc. Natl. Acad. Sci. USA, 77: 1588-1592, 1980.
80. D. Campana, G. Janossy, E. Coustan-Smith, P.L. Amlot, W.T. Tian, S. Ip, and L. Wong, The expression of T cell receptor-associated proteins during T cell ontogeny in man, J. Immunol., 142: 57-66, 1989.
81. R.L. Boyd and P. Hugo, Towards an integrated view of thymopoiesis, Immunol. Today, 12: 71-79, 1991.
82. A. Kumar, J. Haque, J. Lacoste, J. Hiscott, and B.R. Williams, The dsRNA-dependent protein kinase, PKR, activates transcription factor NF-kB by phosphorylating lkB, Proc. Natl. Acad. Sci. USA, 91: 6288-6292, 1994.
83. A. Kumar, Y.L. Yang, V. Flati, S. Der, S. Kadereit, A. Deb, J. Haque, L. Reis, C. Weissmann, and B.R. Williams, Deficient cytolkine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: Role of IRF-1 and NFkappaB, EMBO J., 16: 406-416, 1997.
84. A.H.T. Wong, N.W.N. Tam, Y.L. Yang, A.R. Cuddihy, S. Li, S. Kirchhoff, H. Hauser, T. Decker, and A.E. Koromilas, Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and douvle-stranded RNA signaling pathways, EMBO J., 16: 1291-1304, 1997.
85. T. Ito, R. Jagus, and W.S. May, Interleukin 3 stimulates protein synthesis by regulating double-stranded RNA-dependent protein kinase, Proc. Natl. Acad. Sci. USA, 91: 7455-7459, 1994.
86. K. Nagai, A.H.T. Wong, S. Li, N.W.N. Tam, A.R. Cuddihy, N. Sonenberg, M.B. Mathews, J. Hiscott, M.A. Wainberg, and A.E. Koromilas, Induction of CD4 expression and human immunodeficiency virus type 1 replication by mutants of the interferon-inducible protein kinase PKR, J. Virol., 71: 1718-1725, 1997.
87. S. Kadereit, H. Xu, T.M. Engeman, Y.L. Yang, R.L. Fairchild, and B.R.G. Williams, Negative regulation of CD8 + T cell function by the IFN-induced and double-stranded RNA-activated kinase PKR, J. Immunol., 165: 6896-6901, 2001.
88. A.K. Dayal and G.M. Kammer, The T cell enigma in lupus, Arthritis Rheum., 39: 23-33, 1996.
89. G.C. Tsokos, Lymphocyte abnormalities in human lupus, Clin. Immunol. Immunopathol., 63: 7-9, 1992.
90. G.M. Kammer, A. Perl, B.C. Richardson, and G.C. Tsokos, Abnormal T cell signal transduction in systemic lupus erythematosus, Arthritis Rheum., 46: 1139-1154, 2002.
91. G.M. Kammer, I. Khan, and C. Malemud, Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes, J. Clin. Invest., 94: 422-430, 1994.
92. I.U. Khan, D. Laxminarayana, and G.M. Kammer, Protein kinase A RIβ subunit deficiency in lupus T lymphocytes: Bypassing a block in RIβ translation reconstitutes protein kinase A activity and augments IL-2 production, J. Immunol., 166: 7600-7605, 2001.
93. G.C. Tsokos, B. Kovacs, P.P. Sfikakis, S. Theocharis, S.A. Vogelgesang, and C.S. Via, Defective antigen-presenting cell function in patients with systemic lupus erythematosus: Role of the B7-1 (CD80) costimulatory molecule, Arthritis Rheum., 39: 600-609, 1996.
94. M. Koshy, D. Berger, and M.K. Crow, Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes, J. Clin. Invest., 98: 826-837, 1996.
95. H.K. Wong, G.M. Kammer, G. Dennis, and G.C. Tsokos, Abnormal NF-KappaB activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression, J. Immunol., 163: 1682-1689, 1999.
96. Y.T. Juang, K. Tenbrock, M.P. Nambiar, M.F. Gourley, and G.C. Tsokos, Defective production of functional 98-kDa form of Elf-1 is responsible for the decreased expression of TCR zeta-chain in patients with systemic lupus erythematosus, J. Immunol., 169: 6048-6055, 2002.
97. B. Richardson, L. Scheinbart, J. Strahler, L. Gross, S. Hanash, and M. Johnson, Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis, Arthritis Rheum., 33: 1665-1673, 1990.
98. C. Deng, M.J. Kaplan, J. Yang, D. Ray, Z. Zhang, W.J. McCune, S.M. Hanash, and B.C. Richardson, Decreased Ras-mitogen-activated protein kinase signalling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum., 44: 397-407, 2001.
99. A. Grolleau, M.J. Kaplan, S.M. Hanash, L. Beretta, and B. Richardson, Impaired translational response and increased protein kinase PKR expression in T cells from lupus patients, J. Clin. Invest., 106: 1561-1568, 2000.
100. D.W. Stacey, S. Shelly, T. Watson, K. Elkon, H. Weissbach, and N. Brot, The inhibition of protein synthesis by IgG containing anti-ribosome P autoantibodies from systemice lupus erythematosus patients, Arch. Biochem. Biophys., 267: 398-403, 1988.
101. Q.M. Zong, L. Schummer, L. Hood, and D.R. Morris, Messenger RNA translation state: The second dimension of high-throughout expression screening, Proc. Natl. Acad. Sci. USA, 96: 10362-10636, 1999.
102. G. Johannes, M.S. Carter, M.B. Eisen, P.O. Brown, and P. Sarrow, Identification of eukaryotic mRNAs that are translated at reduced cap binding complex elF4F concentrations using a cDNA microarray, Proc. Natl. Acad. Sci. USA, 96: 13118-13123, 1999.
103. A. Grolleau, J. Bowman, B. Pradet-Balade, E. Puravs, S. Hanash, J.A. Garcia-Sanz, and L. Beretta, Global and specific translational control in T cells in response to rapamycin treatment, J. Biol. Chem., 277: 22175-22184, 2002.